Yodoxin Interactions
There are 96 drugs known to interact with Yodoxin (iodoquinol), along with 4 disease interactions. Of the total drug interactions, 1 is major, and 95 are moderate.
- View all 96 medications that may interact with Yodoxin
- View Yodoxin disease interactions (4)
Most frequently checked interactions
View interaction reports for Yodoxin (iodoquinol) and the medicines listed below.
- abacavir
- abatacept
- Abelcet (amphotericin b lipid complex)
- acamprosate
- Accutane (isotretinoin)
- acetazolamide
- Actemra (tocilizumab)
- Acthar (corticotropin)
- Activase (alteplase)
- Adasuve (loxapine)
- Advair Diskus (fluticasone / salmeterol)
- Aerolate III (theophylline)
- Alaway (ketotifen ophthalmic)
- aliskiren
- allopurinol / lesinurad
- aluminum chloride hexahydrate topical
- amantadine
- amitriptyline / perphenazine
- amlodipine / benazepril
- amoxapine
- amphetamine
- amphetamine / dextroamphetamine
- Amphojel (aluminum hydroxide)
- amphotericin b
- AndroGel (testosterone)
- Anoro Ellipta (umeclidinium / vilanterol)
- Anzemet (dolasetron)
- Apresoline (hydralazine)
- Apriso (mesalamine)
- Lotensin (benazepril)
Yodoxin disease interactions
There are 4 disease interactions with Yodoxin (iodoquinol) which include:
More about Yodoxin (iodoquinol)
- Yodoxin consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: amebicides
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.